| Dr Nadia Valery Kovalchuk, MD | |
|
8118 Good Luck Rd, Lanham, MD 20706-3595 | |
| (301) 552-8014 | |
| Not Available |
| Full Name | Dr Nadia Valery Kovalchuk |
|---|---|
| Gender | Female |
| Speciality | Hospitalist |
| Experience | 33 Years |
| Location | 8118 Good Luck Rd, Lanham, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346259512 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 9705 (Nevada) | Secondary |
| 207R00000X | Internal Medicine | A73868 (California) | Secondary |
| 207R00000X | Internal Medicine | D0058446 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sinai Hospital Of Baltimore | Baltimore, MD | Hospital |
| Holy Cross Hospital | Silver spring, MD | Hospital |
| Adventist Healthcare White Oak Medical Center | Silver spring, MD | Hospital |
| Holy Cross Germantown Hospital | Germantown, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Adfinitas Health At Umcap Llc | 0840677738 | 37 |
| Usacs Integrated Acute Care Services Of Maryland Llc | 4486900172 | 218 |
| Sinai Hospital Of Baltimore, Inc | 0941112346 | 333 |
News Archive
Despite rapid advances in targeted therapies for cancer, tumors commonly develop resistance to treatment. When resistance emerges, tumor cells continue to grow unchecked, despite all attempts to slow cancer progression.
Autoimmune disorders may share certain pathogenic mechanisms with cancer, according to a new report by George Washington University researcher Linda Kusner, Ph.D., published in PLOS ONE on July 22.
Monash University researchers and staff of the Melbourne-based biotechnology company Cerylid Biosciences Ltd, have discovered and developed a new class of anti-clotting drugs that appears to be more effective than aspirin at preventing disease-causing blood clots and has fewer side effects.
The American Cancer Society's Mid-South Division, LiDestri Foods, MDU Resources Group, Inc. and WCA Hospital have received CEO Cancer Gold Standard™ accreditation, recognizing the commitment of these organizations to taking concrete actions to reduce the cancer risk of employees and their families through screenings, early detection, and healthy changes in lifestyle.
Scientists at the University of Michigan Medical School have discovered the biological equivalent of a grocery store bar code on the surface of primitive, blood-forming stem cells in mice. Called hematopoietic stem cells, they give rise to all the different types of specialized cells found in blood.
› Verified 1 days ago
| Entity Name | Emergency Medicine Associates Pa Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134117393 PECOS PAC ID: 8022914522 Enrollment ID: O20070919000389 |
News Archive
Despite rapid advances in targeted therapies for cancer, tumors commonly develop resistance to treatment. When resistance emerges, tumor cells continue to grow unchecked, despite all attempts to slow cancer progression.
Autoimmune disorders may share certain pathogenic mechanisms with cancer, according to a new report by George Washington University researcher Linda Kusner, Ph.D., published in PLOS ONE on July 22.
Monash University researchers and staff of the Melbourne-based biotechnology company Cerylid Biosciences Ltd, have discovered and developed a new class of anti-clotting drugs that appears to be more effective than aspirin at preventing disease-causing blood clots and has fewer side effects.
The American Cancer Society's Mid-South Division, LiDestri Foods, MDU Resources Group, Inc. and WCA Hospital have received CEO Cancer Gold Standard™ accreditation, recognizing the commitment of these organizations to taking concrete actions to reduce the cancer risk of employees and their families through screenings, early detection, and healthy changes in lifestyle.
Scientists at the University of Michigan Medical School have discovered the biological equivalent of a grocery store bar code on the surface of primitive, blood-forming stem cells in mice. Called hematopoietic stem cells, they give rise to all the different types of specialized cells found in blood.
› Verified 1 days ago
| Entity Name | Mdics At Washington Adventist Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558764613 PECOS PAC ID: 8426372343 Enrollment ID: O20150126001039 |
News Archive
Despite rapid advances in targeted therapies for cancer, tumors commonly develop resistance to treatment. When resistance emerges, tumor cells continue to grow unchecked, despite all attempts to slow cancer progression.
Autoimmune disorders may share certain pathogenic mechanisms with cancer, according to a new report by George Washington University researcher Linda Kusner, Ph.D., published in PLOS ONE on July 22.
Monash University researchers and staff of the Melbourne-based biotechnology company Cerylid Biosciences Ltd, have discovered and developed a new class of anti-clotting drugs that appears to be more effective than aspirin at preventing disease-causing blood clots and has fewer side effects.
The American Cancer Society's Mid-South Division, LiDestri Foods, MDU Resources Group, Inc. and WCA Hospital have received CEO Cancer Gold Standard™ accreditation, recognizing the commitment of these organizations to taking concrete actions to reduce the cancer risk of employees and their families through screenings, early detection, and healthy changes in lifestyle.
Scientists at the University of Michigan Medical School have discovered the biological equivalent of a grocery store bar code on the surface of primitive, blood-forming stem cells in mice. Called hematopoietic stem cells, they give rise to all the different types of specialized cells found in blood.
› Verified 1 days ago
| Entity Name | Usacs Integrated Acute Care Services Of Maryland Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922598929 PECOS PAC ID: 4486900172 Enrollment ID: O20190604001354 |
News Archive
Despite rapid advances in targeted therapies for cancer, tumors commonly develop resistance to treatment. When resistance emerges, tumor cells continue to grow unchecked, despite all attempts to slow cancer progression.
Autoimmune disorders may share certain pathogenic mechanisms with cancer, according to a new report by George Washington University researcher Linda Kusner, Ph.D., published in PLOS ONE on July 22.
Monash University researchers and staff of the Melbourne-based biotechnology company Cerylid Biosciences Ltd, have discovered and developed a new class of anti-clotting drugs that appears to be more effective than aspirin at preventing disease-causing blood clots and has fewer side effects.
The American Cancer Society's Mid-South Division, LiDestri Foods, MDU Resources Group, Inc. and WCA Hospital have received CEO Cancer Gold Standard™ accreditation, recognizing the commitment of these organizations to taking concrete actions to reduce the cancer risk of employees and their families through screenings, early detection, and healthy changes in lifestyle.
Scientists at the University of Michigan Medical School have discovered the biological equivalent of a grocery store bar code on the surface of primitive, blood-forming stem cells in mice. Called hematopoietic stem cells, they give rise to all the different types of specialized cells found in blood.
› Verified 1 days ago
| Entity Name | Adfinitas Health At Umcap Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205585940 PECOS PAC ID: 0840677738 Enrollment ID: O20220516000110 |
News Archive
Despite rapid advances in targeted therapies for cancer, tumors commonly develop resistance to treatment. When resistance emerges, tumor cells continue to grow unchecked, despite all attempts to slow cancer progression.
Autoimmune disorders may share certain pathogenic mechanisms with cancer, according to a new report by George Washington University researcher Linda Kusner, Ph.D., published in PLOS ONE on July 22.
Monash University researchers and staff of the Melbourne-based biotechnology company Cerylid Biosciences Ltd, have discovered and developed a new class of anti-clotting drugs that appears to be more effective than aspirin at preventing disease-causing blood clots and has fewer side effects.
The American Cancer Society's Mid-South Division, LiDestri Foods, MDU Resources Group, Inc. and WCA Hospital have received CEO Cancer Gold Standard™ accreditation, recognizing the commitment of these organizations to taking concrete actions to reduce the cancer risk of employees and their families through screenings, early detection, and healthy changes in lifestyle.
Scientists at the University of Michigan Medical School have discovered the biological equivalent of a grocery store bar code on the surface of primitive, blood-forming stem cells in mice. Called hematopoietic stem cells, they give rise to all the different types of specialized cells found in blood.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Nadia Valery Kovalchuk, MD 3209 Geiger Ave, Kensington, MD 20895-1802 Ph: () - | Dr Nadia Valery Kovalchuk, MD 8118 Good Luck Rd, Lanham, MD 20706-3595 Ph: (301) 552-8014 |
News Archive
Despite rapid advances in targeted therapies for cancer, tumors commonly develop resistance to treatment. When resistance emerges, tumor cells continue to grow unchecked, despite all attempts to slow cancer progression.
Autoimmune disorders may share certain pathogenic mechanisms with cancer, according to a new report by George Washington University researcher Linda Kusner, Ph.D., published in PLOS ONE on July 22.
Monash University researchers and staff of the Melbourne-based biotechnology company Cerylid Biosciences Ltd, have discovered and developed a new class of anti-clotting drugs that appears to be more effective than aspirin at preventing disease-causing blood clots and has fewer side effects.
The American Cancer Society's Mid-South Division, LiDestri Foods, MDU Resources Group, Inc. and WCA Hospital have received CEO Cancer Gold Standard™ accreditation, recognizing the commitment of these organizations to taking concrete actions to reduce the cancer risk of employees and their families through screenings, early detection, and healthy changes in lifestyle.
Scientists at the University of Michigan Medical School have discovered the biological equivalent of a grocery store bar code on the surface of primitive, blood-forming stem cells in mice. Called hematopoietic stem cells, they give rise to all the different types of specialized cells found in blood.
› Verified 1 days ago
Dr. Hwaida Hannoush, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 9831 Greenbelt Rd Ste 103, Lanham, MD 20706 Phone: 301-277-3555 Fax: 301-552-0098 | |
Dr. Farhan Ali Shah, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 8118 Good Luck Rd, Lanham, MD 20706 Phone: 301-552-8118 | |
Maheteme Bayeh, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 9801 Greenbelt Rd, Suite 101, Lanham, MD 20706 Phone: 301-552-6666 Fax: 301-552-6216 | |
Dr. Rodney Lane Ellis, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 9811 Greenbelt Rd, Suite 104, Lanham, MD 20706 Phone: 301-552-3953 Fax: 301-552-3957 | |
Dr. Vineet Venugopal, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 8116 Good Luck Rd Ste 305, Lanham, MD 20706 Phone: 301-552-1200 Fax: 301-552-1202 | |
Dr. Vivek Bahl, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 8116 Good Luck Rd Ste 305, Lanham, MD 20706 Phone: 301-552-1200 Fax: 301-552-1202 | |
Ravjyot Chawla, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 8116 Good Luck Rd Ste 305, Lanham, MD 20706 Phone: 301-552-1200 Fax: 301-552-1202 |